Kazia Therapeutics Appoints James Levine as Chief Financial Officer

Go back to Kazia Therapeutics Appoints James Levine as Chief Financial Officer
(NASDAQ: KZIA) Delayed: 12.82 --0 (-0%)
Previous Close $12.82    52 Week High
Open $12.82    52 Week Low
Day High $12.82    P/E N/A 
Day Low $12.82    EPS
Volume 4,701